Aaron Goldman Email & Phone Number
CEO (fractional) @ Oridivus
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Aaron Goldman Location
- Boston, MA, US
Aaron Goldman Work
- 2025 -now CEO (fractional) @
- 2026 -now Member, Scientific Advisory Board @
- 2023 -now Operating Partner @
- 2026 -now Member, Drug Discovery and Efficacy Working Group @
- 2015 -now Director, Drug Resistance Group @
- 2015 -now Faculty, Instructor in Medicine and Director @
- 2011 -2015 Post Doctoral fellow @
- 2025 -now Entrepreneur in Residence @
- 2020 -now Member, Cancer Immunology @
- 2015 -now Associate Bioengineer @
- 2015 -now Director, Drug Resistance Group @
- 2020 -now Translational Technologies, Business and Process Advisor @
- 2021 -now Scientific Advisory Board Member @
- 2023 -now Advisory Board Member @ Tessellate therapeutics
- 2022 -2023 Sr. Director, Translational Research Business Development, Alliance Management @
- 2022 -2022 Sr. Director, Translational Research @
- 2021 -2022 Co-Founder, President and CEO @
- 2019 -2022 Entrepreneur In Residence @
- 2018 -2019 Director, R and D and Global Head of Immuno-Oncology @
- 2016 -2018 Associate Director, R and D and Immuno Oncology @
- 2015 -2019 Legislative Ambassador @
- 2010 -2010 Congressional Intern @
- 2006 -2010 Graduate Student @
- 2007 -2009 Literature Research Scientist @
Aaron Goldman Education
- Harvard Medical School
Post-Doctoral Training (Bioengineering and Biomedical Engineering)
2011-2015 - University of Arizona College of Medicine – Tucson
Doctor of Philosophy (Ph.D.) (Cancer Biology and Medical Pharmacology)
2006-2010 - W.A. Franke Honors College
Bachelor of Science (B.S.) Philosophy (Minor) (Cell/Cellular and Molecular Biology and Philosophy)
2001-2006
Aaron Goldman Skills
- Biotechnology Industry
- Strategic Partnerships
- Life Sciences
- Operational Execution
- Investments
- Corporate Partnership Development
- Oncology Clinical Research
- Biotechnology
- Translational Research
- Cancer Immunotherapy
- Start-up Ventures
- Cell Therapy
- Translational Medicine
- Business Alliance Development
- Drug Development
- Business Development
- Confocal Microscopy
- Molecular Biology
- Fluorescence Microscopy
- Western Blotting
- Molecular Cloning
- Cell Biology
- Flow Cytometry
- Animal Models
- Tissue Culture
- Atomic Absorption
- Atomic Spectroscopy
- Phage Display
- HPLC
- FPLC
- Immunohistochemistry
- Immunocytochemistry
- Biochemistry
- Proteomics
- Cell Culture
- Cancer Research
- Cancer
- Cancer Stem Cells
- Transfection
- Cell
- PCR
- Cell Signaling
- Immunofluorescence
Aaron Goldman Summary
- Aaron Goldman, based in Boston, MA, US, is currently a CEO (fractional) at Oridivus. Aaron Goldman brings experience from previous roles at Harvard Bioscience, BroadOak Capital Partners, International Society for Stem Cell Research and Harvard Medical School. Aaron Goldman holds a 2011 - 2015 Post-Doctoral Training in Bioengineering and Biomedical Engineering @ Harvard Medical School. With a robust skill set that includes Biotechnology Industry, Strategic Partnerships, Life Sciences, Operational Execution, Investments and more. Aaron Goldman has 5 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Aaron Goldman?
Find contact details for 700 million professionals.
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co